Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Ccnd2
REST API REST API
Mus musculus
Ccnd2 is differentially expressed in 328 experiments: 119 organism parts: liver, hippocampus, ... (117 more);, 22 disease states: normal, LPS-induced acute lung injury, ... (20 more);, 77 cell types 30 cell lines 55 compound treatments and 48 other conditions.
Synonyms 'cD2', 'Vin1', 'Vin-1'
Orthologs CCND2_BOVIN (Bos taurus)   CCND2_RAT (Rattus norvegicus)   F6S8K9_CIOIN (Ciona intestinalis)   CCND2 (Homo sapiens)   CCND2_CHICK (Gallus gallus)   CycD (Drosophila melanogaster)   ccnd2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term cytosol, cell division, protein binding, cytoplasm, positive regulation of cell proliferation, membrane, regulation of cyclin-dependent protein kinase activity, spermatogenesis, cell cycle, response to cAMP, regulation of neuron differentiation, regulation of cell cycle, protein kinase binding, G1/S transition of mitotic cell cycle, nucleus, chromatin, response to ethanol, nucleolus, nuclear membrane, cellular response to insulin stimulus, response to testosterone stimulus, positive regulation of epithelial cell proliferation, ovarian follicle development, response to peptide hormone stimulus, response to estradiol stimulus, positive regulation of cyclin-dependent protein kinase activity, liver development, cyclin-dependent protein kinase holoenzyme complex, positive regulation of protein phosphorylation, response to organic cyclic compound
InterPro Term Cyclin-like, Cyclin_N, Cyclin_C, Cyclin_A/B/D/E
Search EB-eye ENSMUSG00000000184
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-3963, E-GEOD-2866, ... (66 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17112, E-MEXP-1689, E-GEOD-21515, E-GEOD-19732, E-GEOD-1956, ... (11 experiments)

Factor Value U/D Experiments
B140H
2
2
E-GEOD-18322, E-GEOD-2788
lewis lung carcinoma (LLC)
1
E-GEOD-17112
Swiss2
1
E-GEOD-19732
neuro2a
1
E-GEOD-10246
67NR
1
1
E-GEOD-11259
mIMCD-3
1
E-GEOD-10246
24 more value(s).


Cell type

studied in E-GEOD-2585, E-GEOD-7069, E-GEOD-7764, E-GEOD-13, E-GEOD-21749, ... (32 experiments)

Factor Value U/D Experiments
hematopoietic stem cell
2
E-GEOD-7069, E-GEOD-20377
pachytene spermatocyte
2
E-GEOD-4193, E-TABM-412
round spermatid
2
E-GEOD-4193, E-GEOD-21749
embryonic stem cell
1
2
E-GEOD-7069, E-GEOD-21515, E-MEXP-955
upper-SP HSC
1
E-GEOD-16475
resting natural killer cell
1
E-GEOD-7764
71 more value(s).


Disease state

studied in E-GEOD-670, E-GEOD-19004, E-GEOD-21927, E-GEOD-6461, E-GEOD-2514, ... (16 experiments)

Factor Value U/D Experiments
high grade prostatic intraepithelial neoplasia
1
E-MEXP-1296
heart failure
1
E-GEOD-670
bronchoalveolar adenocarcinoma
1
1
E-MEXP-1137
prostate carcinoma
1
E-MEXP-1296
neuroblastoma
1
E-GEOD-10246
breast carcinoma
1
E-GEOD-2528
16 more value(s).


Compound treatment

studied in E-GEOD-21711, E-GEOD-6085, E-TABM-903, E-GEOD-4671, E-TABM-310, ... (44 experiments)

Factor Value U/D Experiments
lipopolysaccharide
3
E-GEOD-3565, E-GEOD-2411, E-TABM-310
none
7
9
E-MEXP-1702, E-MEXP-1237, E-MEXP-2282, E-GEOD-2973, E-TABM-141, ... (16 experiments)
doxycycline
2
E-MEXP-1702, E-MEXP-1137
BMP
2
1
E-GEOD-18649
TGF beta 1
1
E-MEXP-1342
forskolin
1
E-GEOD-21711
49 more value(s).


Agent

studied in E-GEOD-32706

Factor Value U/D Experiments
control
1
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

Bioanalyzer results
studied in E-GEOD-18858

cell population
studied in E-GEOD-26086

Clinical info
studied in E-MEXP-1458

Clinical treatment
studied in E-GEOD-2411, E-GEOD-5500

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-1026, E-GEOD-1479, E-GEOD-8191, E-GEOD-7342, E-GEOD-1025, ... (25 experiments)

Diet
studied in E-GEOD-16377

Disease staging
studied in E-GEOD-17112

dose or concentration
studied in E-GEOD-18858

Environmental stress
studied in E-GEOD-16661

Fraction
studied in E-TABM-363

Generation
studied in E-GEOD-6527

Genetic modification
studied in E-GEOD-3172

Genotype
studied in E-GEOD-7020, E-MEXP-1649, E-MEXP-1587, E-TABM-285, E-GEOD-19194, ... (52 experiments)

Growth condition
studied in E-GEOD-4310

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Individual
studied in E-GEOD-18858

Infection
studied in E-MEXP-1190, E-MEXP-1717, E-GEOD-20302, E-MEXP-1942, E-GEOD-2973 ... (5 experiments)

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-5296

Irradiate
studied in E-GEOD-4066

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-5296

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-13, E-GEOD-272, E-GEOD-15840, E-MEXP-1672, E-GEOD-2640 ... (5 experiments)

Population
studied in E-GEOD-1571

Protocol type
studied in E-GEOD-16192, E-GEOD-2917

Rna integrity number
studied in E-GEOD-18858

RNAi
studied in E-MEXP-1342

Route of exposure
studied in E-GEOD-18858

sample preservation
studied in E-GEOD-18858

Sex
studied in E-GEOD-75, E-GEOD-3530

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902, E-GEOD-15901

Strain or line
studied in E-GEOD-21927, E-GEOD-19322, E-GEOD-21515, E-GEOD-16994, E-MTAB-76, ... (22 experiments)

Temperature
studied in E-GEOD-20645

Transfect
studied in E-GEOD-6487

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-22009, E-GEOD-21841, ... (11 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

units of dose or concentration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.188 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM